Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX0YPA
|
||||
Drug Name |
N-(2,4-difluorobenzyl)-N-((4-(4-cyanobenzyl)-4H-1,2,4-triazol-3-yl)methyl)quinoline-2-carboxamide
|
||||
Synonyms |
CHEMBL371484
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C28H20F2N6O
|
||||
Canonical SMILES |
Fc1ccc(CN(Cc2nncn2Cc3ccc(cc3)C#N)C(=O)c4ccc5ccccc5n4)c(F)c1
|
||||
InChI |
InChI=1S/C28H20F2N6O/c29-23-11-9-22(24(30)13-23)16-35(28(37)26-12-10-21-3-1-2-4-25(21)33-26)17-27-34-32-18-36(27)15-20-7-5-19(14-31)6-8-20/h1-13,18H,15-17H2
|
||||
InChIKey |
FBAPTBLKAIFWHJ-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.